• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18524

【品名】2-sulfanylacetic acid

【CA登记号】68-11-1

【 分 子 式 】C2H4O2S

【 分 子 量 】92.11856

【元素组成】C 26.08% H 4.38% O 34.74% S 34.81%

与该中间体有关的原料药合成路线共 11 条

合成路线1

该中间体在本合成路线中的序号:(B)

The reaction of 2-chloro-3,5-dinitrobenzoic acid (I) with thionil chloride, followed by treatment with diethyl ethoxymagnesium malonate gives diethyl 2-chloro-3,5-dinitrobenzoylmalonate (II), which is hydrolyzed and decarboxylated in hot sulfuric acid/propionic acid yielding 2-chloro-3,5-dinitroacetophenone (III). Reaction of (III) with thioglycolic acid by means of NaHCO3 in refluxing isopropanol gives the thioacetic acid compound (IV), which is cyclized in refluxing propionic acid yielding 3-methyl-5,7-dinitrobenzothiophene (V). Partial selective reduction of one of the nitro groups in (V) by means of ammonium sulfide in ethanol leads to 7-amino-3-methyl-5-nitrobenzothiophene (VI), which is diazotied by treatment with NaNO2 in hydrochloric acid. The following reaction with diethylamine in alkaline solution gives the triazene derivative (VII), which is finally fluorinated by reaction with anhydrous HF yielding 7-fluoro-3-methyl-5-nitrobenzothiophene (VIII). Catalytical reduction of (VIII) yields 5-amino-7-fluoro-3-methylbenzothiophene (IX), which is converted to 5-hydrazino-7-fluoro-3-methylbenzothiophene (X) by diazotation and subsequent reduction by means of stannous chloride in hydrochloric acid. The reaction of (X) with N-ethyl-4-piperidone (XI) in refluxing isopropanol gives the corresponding hydrazone, which is cyclized in refluxing isopropanol/HCl yiellding tiflucarbine base. Finally, this compound is converted to the lactate by means of lactic acid in acetone.

1 Urda, E.; Sahi, J.; Wen, Y.-H.; et al.; IXth Intl Symp Med Chem (September 14-18, Berlin) 1986, 30, 9, 977.
2 Schollnhammer, G.; Seidel, P.-R. (Troponwerke GmbH & Co KG); 7,8,9,10-tetrahydrothieno[3,2-e]pyrido[4,3-b]indole, a process for their preparation and medicaments containing them. EP 0120439; US 4816461 .
3 Glaser, T.; Seidel, P.-R.; Tiflucarbine. Drugs Fut 1987, 12, 6, 562.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(A) 28858 diethyl ethoxymagnesiummalonate C9H16MgO5 详情 详情
(I) 28857 2-chloro-3,5-dinitrobenzoic acid 2497-91-8 C7H3ClN2O6 详情 详情
(II) 28859 diethyl 2-(2-chloro-3,5-dinitrobenzoyl)malonate C14H13ClN2O9 详情 详情
(III) 28860 1-(2-chloro-3,5-dinitrophenyl)-1-ethanone C8H5ClN2O5 详情 详情
(IV) 28861 2-[(2-acetyl-4,6-dinitro-2,4-cyclohexadien-1-yl)sulfanyl]acetic acid C10H10N2O7S 详情 详情
(V) 28862 3-methyl-5,7-dinitro-1-benzothiophene C9H6N2O4S 详情 详情
(VI) 28863 3-methyl-5-nitro-1-benzothiophen-7-ylamine C9H8N2O2S 详情 详情
(VII) 28864 (E)-3,3-dimethyl-1-(3-methyl-5-nitro-1-benzothiophen-7-yl)-1-triazene C11H12N4O2S 详情 详情
(VIII) 28865 7-fluoro-3-methyl-5-nitro-1-benzothiophene C9H6FNO2S 详情 详情
(IX) 28866 7-fluoro-3-methyl-1-benzothiophen-5-amine C9H8FNS 详情 详情
(X) 28867 1-(7-fluoro-3-methyl-1-benzothiophen-5-yl)hydrazine C9H9FN2S 详情 详情
(XI) 10919 1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one 1445-73-4 C6H11NO 详情 详情
(XII) 28869 2-hydroxypropionic acid; Lactic acid 50-21-5 C3H6O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(B)

Erdosteine (III) can be obtained in a two-step synthesis starting from homocysteine thiolactone (I). (I) is acylated in chloroform with chloroacetyl chloride (A) to the amide (II). Subsequent reaction with thioglycolic acid (B) gives rise to (III).

1 Gobetti, M.; Pedrazzoli, A.; Bradamante, S.; DL-S-[2-[N-3-(2-Oxotetrahydrothienyl)acetamido]]-thioglycolic acid: A novel mucolytic agent of the class of homocysteine thiolactone derivatives. Farm Sci Ed 1986, 41, 1, 69-79.
2 Fregnan, G.B.; Pappalardo, M.; ERDOSTEINE < Rec INN >. Drugs Fut 1990, 15, 9, 887.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 11296 2-Chloroacetyl chloride; Chloroacetic chloride 79-04-9 C2H2Cl2O 详情 详情
(B) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(I) 22495 3-aminodihydro-2(3H)-thiophenone 10593-85-8 C4H7NOS 详情 详情
(II) 31177 2-chloro-N-(2-oxotetrahydro-3-thiophenyl)acetamide 84611-22-3 C6H8ClNO2S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

The protected ligand (IV) was also prepared by a related method. The acylation of thioglycolic acid (V) with benzoyl chloride (VI) under Schotten-Baumann conditions afforded S-benzoyl thioglycolic acid (VII). After activation of (VII) as the corresponding succinimidyl ester (VIII) with N-hydroxysuccinimide and DCC, coupling with triglycine (I) furnished compound (IV).

1 Grummon, G.; et al.; Synthesis, characterization and crystal structures of technetium(V)-oxo complexes useful in nuclear medicine. 1. Complexes of mercaptoacetylglycylglycylglycine (MAG3) and its methyl ester derivative (MAG3OMe). Inorg Chem 1995, 34, 7, 1764.
2 Brandau, W.; et al.; Technetium-99m labeled renal function and imaging agents. 3. Synthesis of Tc-99m-MAG3 and biodistribution of by-products. Int J Radiat Appl Instrum Part A - Appl Radiat Isotop 1988, 39, 2, 121.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56518 2-({2-[(2-aminoacetyl)amino]acetyl}amino)acetic acid C6H11N3O4 详情 详情
(IV) 56520 1,4,7,10-tetraoxo-1-phenyl-2-thia-5,8,11-triazatridecan-13-oic acid C15H17N3O6S 详情 详情
(V) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(VI) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情
(VII) 56522 2-(benzoylsulfanyl)acetic acid C9H8O3S 详情 详情
(VIII) 56523 S-{2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl} benzenecarbothioate C13H11NO5S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

Other S-protecting groups for mercaptoacetyl triglycine have been reported. The S-benzyl derivative (X) was prepared by condensation of triglycine (I) with (benzylthio)acetyl chloride (IX). Alternatively, the S-benzamidomethyl compound (XII) was prepared as follows. Thioglycolic acid (V) was condensed with benzamidomethanol under acidic conditions to give S-(benzamidomethyl)thioglycolic acid (XI), which was then coupled to triglycine (I) using DCC/HOBt. Deprotection in the presence of 99Tc pertechnetate under the same conditions as above furnished the title Tc complex.

1 Okarvi, S.M.; et al.; Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S-protective groups. J Label Compd Radiopharm 1997, 39, 10, 853.
2 Bormans, G.; et al.; Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine. Nucl Med Biol 1995, 22, 3, 339.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56518 2-({2-[(2-aminoacetyl)amino]acetyl}amino)acetic acid C6H11N3O4 详情 详情
(V) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(IX) 56524 2-(benzylsulfanyl)acetyl chloride C9H9ClOS 详情 详情
(X) 56525 4,7,10-trioxo-1-phenyl-2-thia-5,8,11-triazatridecan-13-oic acid C15H19N3O5S 详情 详情
(XI) 56526 2-{[(benzoylamino)methyl]sulfanyl}acetic acid C10H11NO3S 详情 详情
(XII) 56527 1,6,9,12-tetraoxo-1-phenyl-4-thia-2,7,10,13-tetraazapentadecan-15-oic acid C16H20N4O6S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XXV)

The acylation of 2-butene-1,4-diol (XXII) with butyryl chloride and DMAP in pyridine gives the dibutyrate (XXIII), which is ozonolyzed with O3 in dichloromethane yielding the aldehyde (XXIV). The cyclization of (XXIV) with mercaptoacetic acid (XXV) in refluxing toluene affords 2-(butyryloxymethyl)-1,3-oxathiolane-5-one (XXVI), which is reduced with lithium tri-tert-butoxyaluminum hydride and acetylated with acetic anhydride in THF to give 5-acetoxy-2-(butyryloxymethyl)-1,3-oxathiolane (XXVII). The condensation of (XXVII) with disilylated 5-fluorocytosine (XV) (obtained from cytosine (XVI) as described) by means of SnCl4 in dichloromethane yields the racemic butyryl nucleoside rac-(cis)-(XXVIII). The biological resolution of this racemic mixture has been performed by digestion with the enzyme pig liver esterase (PLE-A) providing a mixture of unreacted (-)-(cis)-(2R,5S)-(XXVIII) butyrate and hydrolyzed (+)-(cis)-(2S,5R)-(XXIX) that are separated by fractional extraction. The desired (-)-(cis)-(2R,5S)-enantiomer is finally hydrolyzed to the target compound with NaOMe in methanol. The biological resolution of rac-(cis)-(XXVIII) can also be performed with the enzyme Amano PS-800 yielding a mixture of unreacted (+)-(cis)-(2S,5R)-(XXVIII) butyrate and the desired (-)-(cis)-(2R,5S) target nuceloside that are separated by fractional extraction.

1 Liotta, D.C.; Schinazi, R.F.; Choi, W.-B. (Emory University); Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane. EP 0984013; JP 1994508605; JP 1998147586; WO 9214743 .
2 Hoong, L.K.; et al.; Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2', 3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds. J Org Chem 1992, 57, 21, 5563.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(rac)-(XXVIII) 36970 (rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(+)-(XXVIII) 36971 [(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(-)-cis-(XXVIII) 36972 (-)-cis-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(XV) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(XVI) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XXII) 36965 (Z)-2-butene-1,4-diol 6117-80-2 C4H8O2 详情 详情
(XXIII) 36966 (Z)-4-(butyryloxy)-2-butenyl butyrate C12H20O4 详情 详情
(XXIV) 36967 2-oxoethyl butyrate C6H10O3 详情 详情
(XXV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(XXVI) 36968 (5-oxo-1,3-oxathiolan-2-yl)methyl butyrate C8H12O4S 详情 详情
(XXVII) 36969 [5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate C10H16O5S 详情 详情
(XXIX) 36963 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone C8H10FN3O3S 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IV)

A new process for the preparation of emtricitabine has been described: The esterification of 2-butene-1,4-diol (I) with butyryl chloride and DMAP in pyridine gives the diester (II), which by ozonolysis with O3 in methanol provides the hemiacetal (III). Cyclization of (III) with 2-mercaptoacetic acid in refluxing toluene affords racemic 2-(butyryloxymethyl)-1,3-oxathiolan-5-one (V), which is submitted to optical resolution to afford the (R)-enantiomer (VI). The reduction of (VI) with Li(t-BuO)3AlH, followed by acetylation with acetic anhydride gives 5-(acetoxy)-2(R)-(butyryloxy)-1,3-oxathiolane (VII), which by treatment with HCl in dichloroethane is converted into 2(R)-(butyryloxy)-5-chloro-1,3-oxathiolane (VIII). Condensation of (VIII) with 5-fluoro-bis(trimethylsilyl)cytosine (IX) ­ obtained by silylation of cytosine (X) with HMDS ­ by means of NaHCO3 in dichloroethane gives a diastereomeric mixture of the butyrate nucleosides (XI), which is hydrolyzed with butylamine in methanol yielding the corresponding diastereomeric mixture of the (2R,5S)-isomer, emtricitabine, and the (2R,5R)-isomer (XII). This mixture is separated by crystallization of the corresponding hydrochlorides obtained by treatment with HCl in methanol/dioxane.

1 Almond, M.; Painter, G.R.; Liotta, D.C.; Cleary, D.; Soria, J. (Emory University; Triangle Pharmaceuticals, Inc.); Method of manufacture of 1,3-oxathiolane nucleosides. WO 0009494 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36965 (Z)-2-butene-1,4-diol 6117-80-2 C4H8O2 详情 详情
(II) 36966 (Z)-4-(butyryloxy)-2-butenyl butyrate C12H20O4 详情 详情
(III) 39681 2-hydroxy-2-methoxyethyl butyrate C7H14O4 详情 详情
(IV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(V) 36968 (5-oxo-1,3-oxathiolan-2-yl)methyl butyrate C8H12O4S 详情 详情
(VI) 39682 [(2R)-5-oxo-1,3-oxathiolan-2-yl]methyl butyrate C8H12O4S 详情 详情
(VII) 39683 [(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate C10H16O5S 详情 详情
(VIII) 39685 [(2R)-5-chloro-1,3-oxathiolan-2-yl]methyl butyrate C8H13ClO3S 详情 详情
(IX) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XI) 36970 (rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(XII) 36984 benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H17NO3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(IV)

Aldehyde (I) was condensed with 3-aminopropanol (II) in refluxing benzene using a Dean-Stark trap to give imine (III) which, without purification, was in turn condensed with a-mercaptoacetic acid (IV) to afford thiazolidinone (V). Treatment of alcohol (V) with PBr3 gave bromide (VI). Then, reaction of (VI) with amine (VII) in the presence of K2CO3 in refluxing acetone produced the target compound.

1 Kato, T.; Ozaki, T.; Tamura, K.; Suzuki, Y.; Akima, M.; Ohi, N.; Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3,5-Di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. J Med Chem 1998, 41, 22, 4309.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14875 3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzaldehyde; 3,5-di(tert-butyl)-4-hydroxybenzaldehyde; 3,5-Di-tert-butyl-4-hydroxybenzaldehyde 1620-98-0 C15H22O2 详情 详情
(II) 18522 3-amino-1-propanol 156-87-6 C3H9NO 详情 详情
(III) 18523 2,6-di(tert-butyl)-4-[[(3-hydroxypropyl)imino]methyl]phenol C18H29NO2 详情 详情
(IV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(V) 18525 2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-3-(3-hydroxypropyl)-1,3-thiazolidin-4-one C20H31NO3S 详情 详情
(VI) 18526 3-(3-bromopropyl)-2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-thiazolidin-4-one C20H30BrNO2S 详情 详情
(VIII) 12561 2-(1,3-Benzodioxol-5-yloxy)-N-methyl-1-ethanamine; N-[2-(1,3-Benzodioxol-5-yloxy)ethyl]-N-methylamine C10H13NO3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(VI)

Title compound has been prepared by several related ways. Alkylation of methyl acetoacetate (I) with n-heptyl bromide (II) in the presence of NaOMe in refluxing MeOH yielded (III), which was brominated in CHCl3 at 0 C to give (IV). Subsequent reaction with triphenylmethyl mercaptan (V) and tetrabutyl ammonium hydroxide in toluene at r.t. provided (XI). Alternatively, beta-ketoester (XI) was prepared from a-mercaptoacetic acid (VI). Thus, protection as the S-trityl compound (VIII) by treatment with triphenylcarbinol (VII) and TFA, followed by condensation with N,O-dimethyl hydroxylamine in the presence of EDC and HOBt afforded N-methoxyamide (IX). Then, Claisen condensation with methyl nonanoate (X) using LDA as the base in THF at -78 C provided ketoester (XI). In order to avoid b-ketoacid decarboxylation, ketone (XI) was reduced to alcohol (XV) with NaBH4 in MeOH at 0 C. This hydroxyester was also prepared by a related route, consisting of protection of methyl mercaptoacetate (XII) as the S-trityl compound (XIII), followed by reduction to aldehyde (XIV) with DIBAL-H and condensation with methyl nonanoate (X). Saponification of methyl ester (XV) with KOH yielded hydroxyacid (XVI). Subsequent coupling with tert-butylglycine amide (XVII) using EDC and HOBt as the condensing agents produced amide (XVIII). Ketoamide (XX) was then obtained by oxidation with Dess-Martin periodinane (XIX). Finally, deprotection of the S-trityl group was effected by trifluoroacetic acid treatment under reducing conditions with triethyl silane to provide the target compound.

1 Campbell, D.A.; Xiao, X.Y.; Harris, D.; Ida, S.; Mortezaei, R.; Ngu, K.; Shi, L.; Tien, D.; Wang, Y.; Navre, M.; Patel, D.V.; Sharr, M.A.; DiJoseph, J.F.; Killar, L.M.; Leone, C.L.; Levin, J.I.; Skotnicki, J.S.; Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors. Bioorg Med Chem Lett 1998, 8, 10, 1157.
2 Campbell, D.A.; Patel, D.V.; Xiao, X.Y. (Affymax Technologies, NV); Novel inhibitors of collagenase-1 and stromelysin-I metalloproteases, pharmaceutical compsns. comprising same and methods of their use. WO 9640204 .
3 Campbell, D.A.; Patel, D.V.; Xiao, X.Y. (Affymax Technologies, NV); Novel inhibitors of metalloproteases, pharmaceutical compsns. comprising same and methods of their use. WO 9640738 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11791 methyl 3-oxobutanoate; Methyl acetoacetate 105-45-3 C5H8O3 详情 详情
(II) 18828 1-bromoheptane 629-04-9 C7H15Br 详情 详情
(III) 18829 methyl 2-acetylnonanoate C12H22O3 详情 详情
(IV) 18830 methyl 2-(2-bromoacetyl)nonanoate C12H21BrO3 详情 详情
(V) 18831 tritylhydrosulfide; triphenylmethanethiol 3695-77-0 C19H16S 详情 详情
(VI) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(VII) 18833 Trityl alcohol; triphenylmethanol 76-84-6 C19H16O 详情 详情
(VIII) 18834 2-(tritylsulfanyl)acetic acid C21H18O2S 详情 详情
(IX) 18835 N-methoxy-N-methyl-2-(tritylsulfanyl)acetamide C23H23NO2S 详情 详情
(X) 18836 methyl nonanoate 1731-84-6 C10H20O2 详情 详情
(XI) 18837 methyl 2-[2-(tritylsulfanyl)acetyl]nonanoate C31H36O3S 详情 详情
(XII) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(XIII) 18839 methyl 2-(tritylsulfanyl)acetate C22H20O2S 详情 详情
(XIV) 18840 2-(tritylsulfanyl)acetaldehyde C21H18OS 详情 详情
(XV) 18841 methyl 2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanoate C31H38O3S 详情 详情
(XVI) 18842 2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanoic acid C30H36O3S 详情 详情
(XVII) 18843 (2S)-2-amino-N,3,3-trimethylbutanamide 89226-12-0 C7H16N2O 详情 详情
(XVIII) 18844 N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanamide C37H50N2O3S 详情 详情
(XIX) 18845 Dess-Martin periodinane; 1,1,1-Triacetoxy-1,2-benziodoxol-3(1H)-one 87413-09-0 C13H13IO8 详情 详情
(XX) 18846 N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-2-[2-(tritylsulfanyl)acetyl]nonanamide C37H48N2O3S 详情 详情

合成路线9

该中间体在本合成路线中的序号:(III)

The title diaryl thiazolidinone was synthesized by condensation between 2,6-dichlorobenzaldehyde (I), 2-amino-6-methylpyridine (II) and mercaptoacetic acid (III) in refluxing toluene.

1 Barreca, M.L.; et al.; Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett 2001, 11, 13, 1793.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27507 2,6-dichlorobenzaldehyde 83-38-5 C7H4Cl2O 详情 详情
(II) 19678 6-methyl-2-pyridinamine; 6-methyl-2-pyridinylamine; 6-amino-2-picoline; 2-Amino-6-methylpyridine 1824-81-3 C6H8N2 详情 详情
(III) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情

合成路线10

该中间体在本合成路线中的序号:(II)

The cyclocondensation of N,N'-bis(3,4-dichlorobenzylidene)ethylenediamine (I) with 2-sulfanylacetic acid (II) in refluxing toluene gives a mixture of the meso (R,S)-isomer and the corresponding racemate (R,R)+(S,S), which is easily separated by HPLC on a Chiracel OD column to obtain the target meso (R,S)-isomer.

1 Vigorita, M.G.; et al.; Synthesis and antiinflammatory, analgesic activity of 3,-3'-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds, Part 10. Bioorg Med Chem Lett 2001, 11, 21, 2791.
2 Gabriella, M.; et al.; 3,3'-Bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanedyl) derivatives ans corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity. Farmaco 1997, 52, 1, 43.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
54420 (2S)-2-(3,4-dichlorophenyl)-3-{2-[(2S)-2-(3,4-dichlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]ethyl}-1,3-thiazolidin-4-one C20H16Cl4N2O2S2 详情 详情
(I) 54419 N-[(Z)-(3,4-dichlorophenyl)methylidene]-N-(2-{[(Z)-(3,4-dichlorophenyl)methylidene]amino}ethyl)amine; N~1~,N~2~-bis[(Z)-(3,4-dichlorophenyl)methylidene]-1,2-ethanediamine C16H12Cl4N2 详情 详情
(II) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情

合成路线11

该中间体在本合成路线中的序号:(V)

 

1 Liotta DC, Schinazi RF, et al.1993. The preparation of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds as anti-HIV nucleosides. US 5210085
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12234 2-Propen-1-ol; Allyl alcohol 107-18-6 C3H6O 详情 详情
(II) 66313 tert-Butylchlorodiphenylsilane;tert-Butyldiphenylchlorosilane;tert-Butyldiphenylsilyl chloride 58479-61-1 C16H19ClSi 详情 详情
(III) 66314 (allyloxy)(tert-butyl)diphenylsilane   C19H24OSi 详情 详情
(IV) 44475 2-[[tert-butyl(diphenyl)silyl]oxy]acetaldehyde C18H22O2Si 详情 详情
(V) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(VI) 66315 2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-one   C20H24O3SSi 详情 详情
(VII) 55072 (2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl acetate C22H28O4SSi 详情 详情
(VIII) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(IX) 66316 4-amino-1-((2S,5R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-yl)-5-fluoropyrimidin-2(1H)-one   C24H28FN3O3SSi 详情 详情
Extended Information